CPI-169  ≥98%

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

库存{{model.attbuying.number}}
包装规格:5mg in glass bottle
溶解性:溶于DMSO(≥100mg/mL)
产品描述:基本信息 产品编号:C10944 产品名称:CPI-169 CAS: 1802175-07-0   储存条件 粉末 -20℃ 四年     分子式: C27H36N4O5S 溶于液体 -80℃ 六个月 分子量: 528.66 -20℃ 一个月 化学名:      Solubility (25°C)   体外 DMSO   Ethanol   Water   体内(现配现用)     <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。   制备储备液   浓度   溶液体积 质量   1mg   5mg   10mg 1mM 1.8916mL 9.4579mL 18.9157mL 5mM 0.3783mL 1.8916mL 3.7832mL 10mM 0.1892mL 0.9458mL 1.8916mL   生物活性 产品描述 一种新颖的,有效的 EZH2 抑制剂,能够抑制 EZH2 WT,EZH2 Y641N 和 EZH1 的活性,IC50 值分别为 0.24nM,0.51nM 和 6.1nM。 靶点/IC50 EZH2 WT 0.24nM (IC50) EZH2 Y641N 0.51nM (IC50) EZH1 6.1nM (IC50)   体外研究 CPI-169 (CPI 169 R-enantiomer) inhibits the catalytic activity of PRC2 with an IC50 of<1nM,decreases cellular levels of H3K27me3 with an EC50 of 70nM,and triggers cell cycle arrest and apoptosis in a variety of cell lines.In KARPAS-422 cells,CPI-169 shows a dose-dependent inhibitory effect on cell viability, and produces synergy anti-proliferative activity when used in combination with ABT-199.In 16 out of 25 NHL cell lines,CPI-169 also suppresses cell growth with GI50 of <5μM. 体内研究 CPI-169 (CPI 169 R-enantiomer) (200 mpk,s.c. BID) is well tolerated in mice with no observed toxic effect or body weight loss.CPI-169 treatment leads to tumor growth inhibition (TGI) of an EZH2 mutant KARPAS-422 DLBCL xenograft.CPI-169 (100 mpk,BID) with a single dose of CHOP leads tumors to rapidly regress and become unpalpable.In mice bearing KARPAS422 xenografts,CPI-169 (200 mg/kg,s.c.) effectively suppresses H3K27me3 levels and results in lymphoma tumor regression without affecting body weight or causing any overt adverse effects.
保存条件:-20℃